IQ Metrics
IIF Certified Assessment Start IQ Test
IIF Certified Assessment
Puzzles & Brain TrainingEmerging evidence

Do Brain Training Apps Work? One Trial Survived 20 Years

A follow-up published in February 2026 tracked 2,802 adults for two decades after five weeks of cognitive training. One of the three training arms showed a lower rate of dementia diagnosis. The other two showed nothing.

Illustration generated for IQ Metrics. No photograph is used. IQ Metrics

What you need to know

  • The ACTIVE study randomised 2,802 older adults in 1998-99 to memory training, reasoning training, speed-of-processing training or no training, and followed them for twenty years.
  • In the twenty-year analysis published in February 2026, the speed-training group that also received booster sessions had dementia diagnosed in 105 of 264 people (40 per cent) against 239 of 491 controls (49 per cent) – a 25 per cent lower incidence, and the only arm to reach statistical significance.
  • Memory training and reasoning training produced no significant difference, which is the pattern the wider literature has shown for two decades: people get better at the trained task, and that improvement does not reliably spread.
  • Nothing in this result shows that a commercial brain-training app raises IQ. The trained skill was a specific laboratory speed task, the outcome was a dementia diagnosis recorded in insurance claims, and no IQ score was an endpoint.

The brain-training industry spent fifteen years making a promise the evidence would not support, and the correction has been just as blunt: play the games and you get better at the games. So a result published in February 2026 is worth reading carefully, because for the first time a randomised trial has followed people for twenty years and found something on the far side of that gap – for exactly one of the three things it tested.

The trial that ran for twenty years

ACTIVE – Advanced Cognitive Training for Independent and Vital Elderly – enrolled 2,802 older adults across six American sites in 1998 and 1999. Each person was randomly assigned to one of four groups: memory training, reasoning training, speed-of-processing training, or a no-contact control group that received nothing. The training itself was short. Up to ten sessions of sixty to seventy-five minutes, spread over five to six weeks. Half of each training group was then randomised again to receive up to four booster sessions, delivered eleven and thirty-five months after the original block.

The twenty-year follow-up, published in Alzheimer's & Dementia: Translational Research & Clinical Interventions, linked those participants to claims-based dementia diagnoses. The headline number belongs to one cell of that design:

  • Speed-of-processing training with boosters: dementia diagnosed in 105 of 264 participants, or 40 per cent.
  • No-contact control: 239 of 491 participants, or 49 per cent.
  • The difference is a roughly 25 per cent lower incidence, and it was the only comparison in the trial to reach statistical significance.
  • Memory training and reasoning training – the two arms that look most like what a consumer app sells – did not differ significantly from the control group.

That is a genuinely unusual finding and it deserves to be reported as one. It is also a single result inside a trial with many arms, measured through an administrative proxy rather than a clinical assessment, in a cohort that has now been followed long enough for a great deal to have happened to it. Treat it as the strongest signal the field has produced, not as the settled answer.

Near transfer, far transfer, and the gap between them

Every argument about brain training is really an argument about one distinction. Near transfer is improvement on the trained task and on tasks that look almost identical to it. Far transfer is improvement on something the training never touched – your memory for where you left your keys, your reasoning at work, your score on a general ability test. Near transfer is easy to produce and has never been in dispute. Far transfer is the thing being sold, and it is the thing that keeps failing to appear.

Near transfer was never in dispute. Far transfer is what is being sold, and it is what keeps failing to appear.

The most thorough review of the question, published by Simons and colleagues in Psychological Science in the Public Interest in 2016, worked through the published trials and reached a conclusion that has aged well: there is solid evidence that people improve on the tasks they practise, considerably weaker evidence that this spreads to closely related tasks, and little compelling evidence that it improves everyday cognitive performance. Later meta-analytic work has kept landing in the same place. It is also why practice on a test raises the score without raising the ability the score is meant to estimate – the mechanism set out in our piece on what repeat testing does to a cognitive ability score.

Speed of processing is a narrower thing than it sounds. In ACTIVE it was trained with a task called useful field of view, which asks you to identify a target at the centre of a screen while simultaneously locating a second target in the periphery, at exposures too short to move your eyes between them. It is a visual attention task with a driving-safety history behind it. It is not thinking faster in any general sense, and it is not what a puzzle app trains.

Why the biggest name in the category paid the FTC

In January 2016 the Federal Trade Commission announced a settlement with Lumos Labs, the maker of Lumosity. The company had advertised that training for ten to fifteen minutes, three or four times a week, would help users perform better at work and at school, and would reduce or delay the cognitive impairment associated with ageing and with serious health conditions. The Commission's position was that the company did not have the evidence to say any of it.

Lumos Labs paid $2 million; a $50 million judgment was entered and then suspended because of the company's finances. The part of the settlement that mattered most was not the money but the requirement attached to it – human clinical testing before making that class of claim again. The case remains the cleanest illustration of the distance between what the category advertises and what it can demonstrate. It is worth noting that the one arm of ACTIVE which produced a twenty-year effect was not a commercial product at all.

What the speed result does and does not license

  • It does not say that brain training raises IQ. No IQ score was an endpoint in this analysis, and general ability was not what the training targeted.
  • It does not transfer to other apps. The result attaches to one specific trained task with boosters, not to puzzle games in general.
  • It does not establish a mechanism. Whether the training changed the brain, changed behaviour such as driving and independence, or delayed the point at which a diagnosis got recorded, is not settled by this design.
  • It does say the boosters mattered. The arm without them did not show the same effect, which is a real constraint on how any of this would ever be delivered.
  • And it does say the question is still open, which is a better position than the category has occupied for most of the past decade.

One further caution is specific to dementia research. A claims-based diagnosis records the moment a doctor coded a condition, and that moment depends on who goes to the doctor, how often, and how alert their clinician is. Groups that differ in engagement with the health system can differ in recorded incidence without differing in underlying disease. The authors are working within the limits of a twenty-year follow-up on a trial designed in the 1990s, and those limits are real ones.

Your own number

Where would your own score land?

If you want to know what your own reasoning looks like right now, take a properly timed test once and read the result with its confidence range rather than chasing a higher number through practice. Our percentile calculator converts a score into a position in the population, and the tools page explains what the range around it means.

Find your IQ score now!
Secure & encryptedInstant results10–20 minutes

How to read the next brain-training claim

The questions that separate a real finding from marketing are short, and the ACTIVE follow-up answers all of them, which is why it earns attention. Ask them of anything else you are shown. What exactly was trained, and for how long? What was measured afterwards, and was it something other than the trained task? Was there a control group, and were people randomly assigned to it? How long was the follow-up? And has it been replicated, or is this the first time anyone has seen it?

  • A study that measures only the trained task has shown near transfer and nothing more.
  • A study without random assignment cannot separate the training from the kind of person who signs up for training.
  • A study with a few dozen participants and a short follow-up will not settle anything, whatever its headline says.
  • An advertisement citing brain science without naming a trial is not citing anything at all.
  • A percentage improvement quoted without the baseline it improved from is unreadable by design.

The honest summary in September 2026 is narrower than either side would like. Commercial brain-training products reliably make you better at their own exercises, and there is still no good evidence that this raises general ability. One tightly specified laboratory intervention, reinforced with boosters, is now associated with a lower rate of recorded dementia twenty years later. Both things are true at once, and the distance between them is the whole story. If you are curious about the underlying trait rather than the training, our piece on when different abilities actually peak is the better guide to what changes with age – and you can take the test or open the percentile calculator to see where your reasoning sits today.

Common questions

Do brain training apps actually work?

They reliably improve your performance on their own exercises. The evidence that this improvement spreads to untrained everyday abilities – what researchers call far transfer – remains weak, which is what the major review by Simons and colleagues concluded in 2016 and what later meta-analytic work has continued to find. The twenty-year ACTIVE follow-up published in February 2026 is the strongest counter-signal so far, but it involved a specific laboratory speed task with booster sessions, not a commercial app.

Can brain training raise your IQ?

There is no good evidence that it can. Training raises scores on the trained task, and repeated practice on a test raises the test score, but neither is the same as raising the underlying general ability an IQ score estimates. No IQ measure was an endpoint in the ACTIVE dementia analysis.

What did the ACTIVE study find after twenty years?

Among participants randomised to speed-of-processing training with booster sessions, dementia was diagnosed in 105 of 264 people (40 per cent), against 239 of 491 in the no-training control group (49 per cent) – roughly a 25 per cent lower incidence. It was the only arm of the trial to show a statistically significant difference; memory training and reasoning training did not.

Why did Lumosity pay the FTC $2 million?

In January 2016 the Federal Trade Commission settled charges that Lumos Labs had advertised, without adequate supporting evidence, that its games improved performance at work and school and reduced or delayed age-related cognitive impairment. The company paid $2 million, a $50 million judgment was suspended, and it was required to have human clinical testing before making such claims again.

Sources for this story

  1. Coe and colleagues, on claims-based diagnosed dementia over 20 years in the ACTIVE study (2026), doi:10.1002/trc2.70197 — Alzheimer's & Dementia: Translational Research & Clinical Interventions
  2. News release on the twenty-year ACTIVE cognitive-training follow-up (February 2026) — Johns Hopkins Medicine
  3. Simons and colleagues, "Do Brain-Training Programs Work?" (2016) — Psychological Science in the Public Interest
  4. Lumosity to Pay $2 Million to Settle FTC Deceptive Advertising Charges (January 2016) — Federal Trade Commission
  5. Ball and colleagues, on the original ACTIVE randomised controlled trial (2002) — JAMA

Corrections: spotted an error? Email corrections@iqmetrics.org and we will update this story and note the change here.

Share this story

Know someone who keeps seeing this number quoted without the scale it was measured on? Send it to them — it takes one tap.

Filed under#brain training#processing speed#aging and dementia#study quality

Read the research.
Then find your own number.

Our IIF-certified assessment reports your score with its scale, percentile and confidence range — and a breakdown of the cognitive domains behind it.

Start IQ Test
Secure & encryptedInstant results10–20 minutes